Menu
Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Journal Metrics
ESCI
Impact Factor
Blood and Lymphatic Cancer: Targets and Therapy
ISSN: 1179-9889
Usage:
- 22,500 Annual downloads/views
Speed/ acceptance:
- 21% acceptance rate
Citation metrics:
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
- 2.8 Impact Factor *
- PubMed and PubMed Central (Blood Lymphat Cancer)
- Embase, from 2011 (Correct as at December 8, 2016)
- Directory of Open Access Journals (DOAJ)
- The Open Access Initiative (OAIster)
*
- Emerging Sources Citation Index (ESCI)
For more details, please read our journal metrics summary.